Cystatin C, kidney function, and cardiovascular risk factors in primary hypertension

Detalhes bibliográficos
Autor(a) principal: Salgado,João Victor
Data de Publicação: 2013
Outros Autores: França,Ana Karina, Cabral,Nayra Anielly, Lages,Joyce, Ribeiro,Valdinar Sousa, Santos,Alcione Miranda, Salgado,Bernardete Jorge
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista da Associação Médica Brasileira (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302013000100007
Resumo: OBJECTIVE: To investigate the clinical usefulness of serum cystatin C (Scys) and cystatin C-based equations for the screening of chronic kidney disease in primary hypertensive patients, and correlate these markers with risk factors for cardiovascular disease. METHODS: A cross-sectional study was performed in 199 middle-aged adults at a basic health unit. Kidney function assessment included measurements of serum creatinine (Scr) and Scys levels, 24-hour microalbuminuria (MA), as well as glomerular filtration rate (GFR) through Larsson and Modification of Diet in Renal Disease (MDRD) study equations. Bland- Altman plot analysis was used to calculate the agreement between equations. RESULTS: High levels of Scys were found in 22% of the patients, even with normal values of GFR estimated by MDRD study equation. Systolic blood pressure and MA correlated better with Scys than Scr, but there was no correlation between Scys and diastolic blood pressure. Gender, age &gt; 60 years, MA, and uric acid were significantly associated with high Scys levels. After multivariate analysis, only age &gt; 60 yrs (RR = 6.4; p < 0.001) and male gender (RR = 3.0; p = 0.006) remained associated with high Scys levels. CONCLUSION: Cystatin C can be used as a screening marker both for detecting mild declines of renal function and for preventing the risk of cardiovascular events in hypertensive subjects with presumably normal renal function.
id AMB-1_7d45ff5a9d52bf5682d139f42bd4274b
oai_identifier_str oai:scielo:S0104-42302013000100007
network_acronym_str AMB-1
network_name_str Revista da Associação Médica Brasileira (Online)
repository_id_str
spelling Cystatin C, kidney function, and cardiovascular risk factors in primary hypertensionPrimary hypertensionChronic kidney diseaseCardiovascular riskGlomerular filtratin ratePrimary careCystatin COBJECTIVE: To investigate the clinical usefulness of serum cystatin C (Scys) and cystatin C-based equations for the screening of chronic kidney disease in primary hypertensive patients, and correlate these markers with risk factors for cardiovascular disease. METHODS: A cross-sectional study was performed in 199 middle-aged adults at a basic health unit. Kidney function assessment included measurements of serum creatinine (Scr) and Scys levels, 24-hour microalbuminuria (MA), as well as glomerular filtration rate (GFR) through Larsson and Modification of Diet in Renal Disease (MDRD) study equations. Bland- Altman plot analysis was used to calculate the agreement between equations. RESULTS: High levels of Scys were found in 22% of the patients, even with normal values of GFR estimated by MDRD study equation. Systolic blood pressure and MA correlated better with Scys than Scr, but there was no correlation between Scys and diastolic blood pressure. Gender, age &gt; 60 years, MA, and uric acid were significantly associated with high Scys levels. After multivariate analysis, only age &gt; 60 yrs (RR = 6.4; p < 0.001) and male gender (RR = 3.0; p = 0.006) remained associated with high Scys levels. CONCLUSION: Cystatin C can be used as a screening marker both for detecting mild declines of renal function and for preventing the risk of cardiovascular events in hypertensive subjects with presumably normal renal function.Associação Médica Brasileira2013-02-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302013000100007Revista da Associação Médica Brasileira v.59 n.1 2013reponame:Revista da Associação Médica Brasileira (Online)instname:Associação Médica Brasileira (AMB)instacron:AMB10.1590/S0104-42302013000100007info:eu-repo/semantics/openAccessSalgado,João VictorFrança,Ana KarinaCabral,Nayra AniellyLages,JoyceRibeiro,Valdinar SousaSantos,Alcione MirandaSalgado,Bernardete Jorgeeng2015-07-21T00:00:00Zoai:scielo:S0104-42302013000100007Revistahttps://ramb.amb.org.br/ultimas-edicoes/#https://old.scielo.br/oai/scielo-oai.php||ramb@amb.org.br1806-92820104-4230opendoar:2015-07-21T00:00Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB)false
dc.title.none.fl_str_mv Cystatin C, kidney function, and cardiovascular risk factors in primary hypertension
title Cystatin C, kidney function, and cardiovascular risk factors in primary hypertension
spellingShingle Cystatin C, kidney function, and cardiovascular risk factors in primary hypertension
Salgado,João Victor
Primary hypertension
Chronic kidney disease
Cardiovascular risk
Glomerular filtratin rate
Primary care
Cystatin C
title_short Cystatin C, kidney function, and cardiovascular risk factors in primary hypertension
title_full Cystatin C, kidney function, and cardiovascular risk factors in primary hypertension
title_fullStr Cystatin C, kidney function, and cardiovascular risk factors in primary hypertension
title_full_unstemmed Cystatin C, kidney function, and cardiovascular risk factors in primary hypertension
title_sort Cystatin C, kidney function, and cardiovascular risk factors in primary hypertension
author Salgado,João Victor
author_facet Salgado,João Victor
França,Ana Karina
Cabral,Nayra Anielly
Lages,Joyce
Ribeiro,Valdinar Sousa
Santos,Alcione Miranda
Salgado,Bernardete Jorge
author_role author
author2 França,Ana Karina
Cabral,Nayra Anielly
Lages,Joyce
Ribeiro,Valdinar Sousa
Santos,Alcione Miranda
Salgado,Bernardete Jorge
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Salgado,João Victor
França,Ana Karina
Cabral,Nayra Anielly
Lages,Joyce
Ribeiro,Valdinar Sousa
Santos,Alcione Miranda
Salgado,Bernardete Jorge
dc.subject.por.fl_str_mv Primary hypertension
Chronic kidney disease
Cardiovascular risk
Glomerular filtratin rate
Primary care
Cystatin C
topic Primary hypertension
Chronic kidney disease
Cardiovascular risk
Glomerular filtratin rate
Primary care
Cystatin C
description OBJECTIVE: To investigate the clinical usefulness of serum cystatin C (Scys) and cystatin C-based equations for the screening of chronic kidney disease in primary hypertensive patients, and correlate these markers with risk factors for cardiovascular disease. METHODS: A cross-sectional study was performed in 199 middle-aged adults at a basic health unit. Kidney function assessment included measurements of serum creatinine (Scr) and Scys levels, 24-hour microalbuminuria (MA), as well as glomerular filtration rate (GFR) through Larsson and Modification of Diet in Renal Disease (MDRD) study equations. Bland- Altman plot analysis was used to calculate the agreement between equations. RESULTS: High levels of Scys were found in 22% of the patients, even with normal values of GFR estimated by MDRD study equation. Systolic blood pressure and MA correlated better with Scys than Scr, but there was no correlation between Scys and diastolic blood pressure. Gender, age &gt; 60 years, MA, and uric acid were significantly associated with high Scys levels. After multivariate analysis, only age &gt; 60 yrs (RR = 6.4; p < 0.001) and male gender (RR = 3.0; p = 0.006) remained associated with high Scys levels. CONCLUSION: Cystatin C can be used as a screening marker both for detecting mild declines of renal function and for preventing the risk of cardiovascular events in hypertensive subjects with presumably normal renal function.
publishDate 2013
dc.date.none.fl_str_mv 2013-02-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302013000100007
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302013000100007
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S0104-42302013000100007
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Médica Brasileira
publisher.none.fl_str_mv Associação Médica Brasileira
dc.source.none.fl_str_mv Revista da Associação Médica Brasileira v.59 n.1 2013
reponame:Revista da Associação Médica Brasileira (Online)
instname:Associação Médica Brasileira (AMB)
instacron:AMB
instname_str Associação Médica Brasileira (AMB)
instacron_str AMB
institution AMB
reponame_str Revista da Associação Médica Brasileira (Online)
collection Revista da Associação Médica Brasileira (Online)
repository.name.fl_str_mv Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB)
repository.mail.fl_str_mv ||ramb@amb.org.br
_version_ 1754212830684381184